Hydroxychloroquine and "off-label" utilization in the treatment of oral conditions
- PMID: 32331804
- PMCID: PMC7151388
- DOI: 10.1016/j.oooo.2020.03.047
Hydroxychloroquine and "off-label" utilization in the treatment of oral conditions
References
-
- Lanese N. Could the anti-malarial drug chloroquine treat COVID-19? Available at: https://www.livescience.com/chloroquine-coronavirus-treatment.html. Accessed March 22, 2020.
-
- Islam M.N., Cohen D.M., Ojha J., Stewart C.M., Katz J., Bhattacharyya I. Chronic ulcerative stomatitis: diagnostic and management challenges—four new cases and review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:194–203. - PubMed
-
- Rempenault C., Combe B., Barnetche T. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2018;77:98–103. - PubMed
-
- Fourie J., van Heerden W.F., McEachen S.C., van Zyl A. Chronic ulcerative stomatitis: a distinct clinical entity. South Afr Dent J. 2011;66:119–121. - PubMed
-
- Cankaya H., Alpöz E., Karabulut G., Güneri P., Boyacioglu H., Kabasakal Y. Effects of hydroxychlorquine on salivary flow rates and oral complaints of Sjogren patients: a prospective sample study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:62–67. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources